Mohammedulla Khaishgi - Feb 19, 2025 Form 4 Insider Report for IBEX Ltd (IBEX)

Role
Director
Signature
Lisa Lenstrohm, Attorney-in-Fact
Stock symbol
IBEX
Transactions as of
Feb 19, 2025
Transactions value $
-$740,189
Form type
4
Date filed
2/20/2025, 05:32 PM
Previous filing
Feb 18, 2025
Next filing
Feb 21, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBEX Common Shares Sale -$78.1K -2.98K -28.96% $26.19 7.31K Feb 19, 2025 As trustee of the Allibhoy Khaishgi Family Foundation F1
transaction IBEX Common Shares Sale -$328K -12.6K -10.95% $26.05 103K Feb 19, 2025 Direct F2
transaction IBEX Common Shares Sale -$334K -12.6K -12.29% $26.50 89.9K Feb 20, 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $26.185 to $26.21; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F2 This transaction was executed in multiple trades at prices ranging from $25.78 to $26.23; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3 This transaction was executed in multiple trades at prices ranging from $26.235 to $26.629; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.